Anti-GAS2 monoclonal antibody

Pre-made anti-GAS2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GAS2/GAS2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2521-Ab-1/ GM-Tg-hg-IP2521-Ab-2Anti-Human GAS2 monoclonal antibodyHuman
GM-Tg-rg-IP2521-Ab-1/ GM-Tg-rg-IP2521-Ab-2Anti-Rat GAS2 monoclonal antibodyRat
GM-Tg-mg-IP2521-Ab-1/ GM-Tg-mg-IP2521-Ab-2Anti-Mouse GAS2 monoclonal antibodyMouse
GM-Tg-cynog-IP2521-Ab-1/ GM-Tg-cynog-IP2521-Ab-2Anti-Cynomolgus/ Rhesus macaque GAS2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2521-Ab-1/ GM-Tg-felg-IP2521-Ab-2Anti-Feline GAS2 monoclonal antibodyFeline
GM-Tg-cang-IP2521-Ab-1/ GM-Tg-cang-IP2521-Ab-2Anti-Canine GAS2 monoclonal antibodyCanine
GM-Tg-bovg-IP2521-Ab-1/ GM-Tg-bovg-IP2521-Ab-2Anti-Bovine GAS2 monoclonal antibodyBovine
GM-Tg-equg-IP2521-Ab-1/ GM-Tg-equg-IP2521-Ab-2Anti-Equine GAS2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2521-Ab-1/ GM-Tg-hg-IP2521-Ab-2; GM-Tg-rg-IP2521-Ab-1/ GM-Tg-rg-IP2521-Ab-2;
GM-Tg-mg-IP2521-Ab-1/ GM-Tg-mg-IP2521-Ab-2; GM-Tg-cynog-IP2521-Ab-1/ GM-Tg-cynog-IP2521-Ab-2;
GM-Tg-felg-IP2521-Ab-1/ GM-Tg-felg-IP2521-Ab-2; GM-Tg-cang-IP2521-Ab-1/ GM-Tg-cang-IP2521-Ab-2;
GM-Tg-bovg-IP2521-Ab-1/ GM-Tg-bovg-IP2521-Ab-2; GM-Tg-equg-IP2521-Ab-1/ GM-Tg-equg-IP2521-Ab-2
Products NameAnti-GAS2 monoclonal antibody
Formatmab
Target NameGAS2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GAS2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2521-Ag-1Recombinant multi-species GAS2/ GAS-2 protein
    ORF Viral VectorpGMLP004922human GAS2 Lentivirus plasmid
    ORF Viral VectorvGMLP004922human GAS2 Lentivirus particle
    ORF Viral VectorpGMLPm004168mouse Gas2 Lentivirus plasmid
    ORF Viral VectorvGMLPm004168mouse Gas2 Lentivirus particle


    Target information

    Target IDGM-IP2521
    Target NameGAS2
    Gene ID2620,14453,499156,700952,476889,101086419,614840,100057503
    Gene Symbol and SynonymsGAS-2,GAS2,RGD1563167
    Uniprot AccessionO43903
    Uniprot Entry NameGAS2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000148935
    Target ClassificationN/A

    The target: GAS2, gene name: GAS2, also named as GAS-2. The protein encoded by this gene is a caspase-3 substrate that plays a role in regulating microfilament and cell shape changes during apoptosis. It can also modulate cell susceptibility to p53-dependent apoptosis by inhibiting calpain activity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.